The independent source for health policy research, polling, and news.
821-840 of 113,127 results
Results of the long-awaited clinical trial of the drug daraxonrasib were presented Sunday at the American Society of Clinical Oncology’s meeting in Chicago. “Unprecedented,” “compelling,” and “spectacular” are some of the words being used to describe the results, The Washington Post reports.
The FDA expanded the approved use for the inhaled insulin drug Afrezza on Friday. ABC News reports it is now approved for kids 6 years and older with Type 1 diabetes or those who require insulin with Type 2 diabetes. Plus: AI use as a diagnostic tool; Massachusetts vs. UnitedHealthcare in alleged Medicaid fraud case; and more.
Meta, TikTok, Snap Inc., and YouTube all settled with Kentucky's Breathitt County School District, avoiding a trial, Bloomberg reports, adding that more than 1,300 other school districts have filed similar lawsuits and are awaiting trial.
“Protecting Kenyans requires more than hoping diseases do not cross our borders,” the nation's Health Ministry said in a statement over the weekend. Kenyan health officials said Sunday that the facility is for "everyone," not just Americans. Plus: Suspected Ebola cases in Brazil and Italy are being investigated; the recovery of five patients prompts hope; and more.
In an executive order on Friday, President Donald Trump endorsed the new schedule, which reduces the number of recommended childhood vaccinations from 17 to 11, The Hill reports. Meanwhile, ProPublica reports on how efforts to combat gun violence have changed under the Trump administration.
Today's early morning highlights from the major news organizations.
Editorial writers discuss these public health issues.
Each week, KFF Health News finds longer stories for you to enjoy. Today's selections are on 911 dispatchers, suntans, longevity, and more.
The cohort study found that Alzheimer's pathology can be detected in midlife in about 6% of adults. The changes are detected via blood markers and are linked to subtle cognitive differences. Also: The FDA relaxes oversight on blood pressure wearables.
Wednesday's ruling blocks a Van Buren Township landfill from receiving the radioactive waste. Republic Services owns the waste facility and plans to appeal the decision. The site "is specifically engineered to handle ... complex waste streams," a spokesperson said.
Also, the U.S. government will allow American cruise ship passengers exposed to the hantavirus to return home as early as Monday, but they must remain under constant state supervision for the remaining three weeks of their six-week quarantine.
The Trump administration had reached an agreement with the Kenyan government that would have allowed Americans exposed to the deadly virus to isolate in the East African nation. A human rights groups contends the plan poses “grave health risks” to the public, Bloomberg reports. The Kenyan judge will hear arguments in the case June 2.
The Vaccines and Related Biological Products Advisory Committee also discussed the "cicada" variant but in the end decided to focus on the current dominant strain.
Although the rate has held steady for the past few years, Modern Healthcare reports the nonpartisan Congressional Budget Office projects 10 million people will lose coverage over the next decade due to changes in health programs instituted by the Trump administration.
Today's early morning highlights from the major news organizations.
Opinion writers tackle these public health topics.
Each week, KFF Health News compiles a selection of health policy studies and briefs.
The new law, set to take effect Oct. 1, targets the "cruciform trigger bar." The device, which is known as a “Glock switch” even though it isn't affiliated with the manufacturer, allows weapons to be converted to illegal, fully automatic firearms, The Baltimore Sun explained. Residents who already own them will be grandfathered in.
In an interview with the former first lady, slated to air on CBS News this Sunday, Jill Biden discusses former President Joe Biden's performance at the debate. Plus: Pam Bondi's cancer recovery; pricing for new drugs under President Donald Trump; and more.
Altman, who is founding president and chief executive of the nonprofit health policy organization, will step down at the end of 2026, he announced Wednesday. The New York Times noted that under his tenure, KFF has become a primary supplier of information and data on many of the most fiercely debated topics in healthcare, including the Affordable Care Act, vaccines, and gender-affirming care. (The Morning Briefing is part of KFF Health News, one of the three major operating programs at KFF.)
© 2026 KFF